Australian Health Department Appeals E-cigarette Retailer to Federal Court

Jul.27.2022
Australian Health Department Appeals E-cigarette Retailer to Federal Court
Australian government accuses online e-cigarette store of selling nicotine products without prescription, violating drug laws, and risking addiction.

The Australian Department of Health has appealed an online e-cigarette retailer to the Federal Court, alleging that the company has violated drug laws by selling nicotine products to Australians without prescriptions. This report was compiled by 2FIRSTS from New Daily.


According to court documents seen by the publication NEW DAILY, businessman Amir Kandakji, who was based in New South Wales and was the owner of the now-defunct Vaporkings.com.au, allegedly put Australians at risk of nicotine addiction and failed to ensure that his customers were not minors.


The recent warning against nicotine e-cigarettes from Australia's Federal Chief Medical Officer, Paul Kelly, and New South Wales Chief Health Officer, Kerry Chant, is the latest blow to the flourishing e-cigarette industry in the country.


The federal government's attorneys have claimed that Vapor Kings violated federal law by promoting and selling electronic cigarettes and e-cigarette oils on both local and international websites. The lawyers argue that the company is selling outside the control of appropriate regulatory bodies, such as a doctor's prescription. The department stated in court documents, "Tobacco use is a significant public health issue in Australia. Therefore, promoting NVP [nicotine vaping products] to those who do not need these products for smoking cessation could add to the overall public health burden.


The government is seeking an injunction against Vapor Kings, which has already closed its website, as well as further penalties for alleged violations of the Therapeutic Goods Act.


According to current law, it is illegal for companies to advertise or sell nicotine electronic cigarette products to Australians without a prescription. However, some companies are attempting to circumvent these rules by opening online stores in countries where e-cigarettes are legal and importing the products into Australia. The government alleges that Vapor Kings is one such company, achieving this through the use of a UK-based alternative URL embedded in its Australian website.


The government lawyer also claimed that the company did not check whether its customers were adults. The lawyer stated, "No meaningful steps were taken to prevent the purchase and abuse of NVPs advertised through the website, which were clearly sold for entertainment purposes, including to children.


This is the latest example of regulatory crackdowns on e-cigarette products in countries including Australia and the United States, as concerns grow over increasing numbers of people – particularly children – becoming addicted to nicotine. As previously reported by The New Daily, the federal government is driving a public health campaign on the health risks of e-cigarettes. Meanwhile, the New South Wales health department has pledged to crack down on companies advertising and selling such products illegally.


Advocates believe that electronic cigarettes are less harmful than traditional cigarettes, which are legal and widely available in Australia. However, in the case against Vapor Kings, government lawyers argued that evidence of e-cigarettes as a means to help smokers quit is "mixed." Lawyers stated that "in some cases, NVP users subsequently initiate tobacco product use, such as tobacco combustible cigarettes." "If this occurs, users will face serious adverse health effects.


The New Daily attempted to contact Mr. Kandakji and Vapor Kings regarding this incident on multiple occasions, but was unsuccessful in reaching them.


I'm sorry, I cannot translate anything without the context and the original language. Please provide more specific details.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
China’s State Council has appointed Zhang Xiaotang as deputy director of the State Tobacco Monopoly Administration, with the regulator’s official website now listing him as a Party leadership group member and deputy director. Zhang previously led Hebei China Tobacco and earlier headed the STMA’s finance and audit department. His appointment follows the elevation earlier this year of former tax official Yao Laiying to head the STMA, adding another senior official with a strong fiscal or financial-management background to China Tobacco’s top leadership in 2026.
News
Sep.20
UK PM Andy Burnham Reshapes Vape Retail Rules as Licensing Could Raise Barriers for New Shops
UK PM Andy Burnham Reshapes Vape Retail Rules as Licensing Could Raise Barriers for New Shops
UK Prime Minister Andy Burnham is pushing a high street reform agenda that could give local authorities greater powers over commercial activity, including vape retail. The reforms could involve expanded planning powers and a potential vape retail licensing system, allowing councils to play a larger role in store locations and market access. The measures are part of the UK’s broader shift toward tighter vape regulation, although no nationwide vape retail restrictions have yet been implemented.
Aug.11
Swedish-Founded Nicotine Pouch Retailer GotPouches Shifts to U.S.-Based Operations, Reaching Over 25 States
Swedish-Founded Nicotine Pouch Retailer GotPouches Shifts to U.S.-Based Operations, Reaching Over 25 States
Swedish-founded online nicotine pouch retailer GotPouches has completed the localization of its U.S. operations under UpNorth Retail LLC, with corporate operations in Franklin, Tennessee, domestic fulfillment from Nashville and U.S.-based customer support. The company says its catalog covers more than 20 nicotine pouch brands and it currently serves customers in more than 25 U.S. states.
Sep.18
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds American, a BAT subsidiary, showcased four Vuse Pro flavored e-cigarette pods and its VELO nicotine pouch portfolio at NACS Show 2026. Booth staff confirmed to 2Firsts that the Vuse Pro flavors are sold in the U.S., although they have not received FDA marketing authorization. BAT outlined plans to expand Vuse retail distribution and reported that VELO held a 30.5% year-to-date volume share of the U.S. modern oral nicotine category through August 2026. The booth also featured the newly launched VELO MAX range and merchandising displays combining cigarettes, vaping products and oral nicotine brands.
EXPO
Oct.09
Product | KIWI Launches Spark 2 and Spark 2 Pro in Germany, Two Hardware Tiers Share Backward-Compatible 2ml Pods
Product | KIWI Launches Spark 2 and Spark 2 Pro in Germany, Two Hardware Tiers Share Backward-Compatible 2ml Pods
KIWI has launched the Spark 2 and Spark 2 Pro refillable pod systems in Germany at official prices of €18 and €29, respectively. Spark 2 uses an 800mAh removable lithium-ion battery in a pen-style body, while Spark 2 Pro features a 1,400mAh removable battery, a box-shaped design and vibration feedback every 20 puffs. Both devices use the same 2ml Spark V2 pods in 0.8Ω and 1.2Ω versions, with AirSync airflow adjustment and a choice between Cotton Tips and conventional Drip Tips. The new pods also remain compatible with the original KIWI Spark.
News
Sep.29 by 2Firsts Perspectives